Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baveno VII Criteria-guided Initiation of Non-selective Beta Blocker in Patients With Compensated Advanced Chronic Liver Disease to Reduce Hepatic Decompensation: an Open-label Randomised Controlled Trial

NCT06449339 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT06449339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baveno VII Criteria-guided Initiation of Non-selective Beta Blocker in Patients With Compensated Advanced Chronic Liver Disease to Reduce Hepatic Decompensation: an Open-label Randomised Controlled Trial
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 4
Overall status
Recruiting
Start date
July 17, 2024
Completion date
July 30, 2031
Enrollment
474 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced chronic liver disease, hepatic decompensation, portal hypertension